Going global

Lee, Jaimy
June 2011
Modern Healthcare;6/27/2011, Vol. 41 Issue 26, p16
Trade Publication
The article reports that the U.S. Food and Drug Administration (FDA) launched its program called Pathway to Global Product Safety and Quality to improve its global strategy. The FDA will create global coalitions with other countries' regulators and will develop an international data information system. It will enhance its capabilities in information technology, risk analysis and resource allocation. The agency was also mandated to improve its oversight of medical device imports and product recalls.


Related Articles

  • More transparency hasn't translated into import safety. SEREBROV, MARI // Medical Device Daily;5/28/2013, Vol. 17 Issue 102, p1 

    The article talks about the continued concern for safety by the U.S. regarding Chinese imports despite increase in transparency and collaboration between the two nations. The author says that the U.S. Food and Drug Administration (FDA) has 74 active import alerts with regards to drugs and...

  • FDA releases proposed rule on Unique Device System for medical devices.  // Healthcare Purchasing News;Aug2012, Vol. 36 Issue 8, p6 

    The article presents information on a proposed ruling on a Unique Device System for medical devices which has been released in 2012 by the U.S. Food and Drug Administration and discusses the benefits which a Unique Device System can offer.

  • Getting the most out of unique device identification. Conway, Karen // Healthcare Purchasing News;Aug2012, Vol. 36 Issue 8, p60 

    The article reports on a proposed rule for unique device identification in health care facilities which was issued by the U.S. Food and Drug Administration on July 3, 2012. and will require that medical suppliers identify their devices for distribution and use. A discussion of the impact that...

  • FDA Issues Report on Improving Post-Market Device Surveillance.  // PT in Motion;Nov2012, Vol. 4 Issue 10, p36 

    The article offers information on a report issued by the FDA outlining its approach to improving its post-market surveillance system for medical devices, which include the establishment of a unique device identification (UDI) system and promote its incorporation into electronic health information.

  • U.S. companies losing ground. Barr, Paul // Modern Healthcare;3/7/2011, Vol. 41 Issue 10, p30 

    The article looks at a report by PricewaterhouseCoopers in the U.S. titled "Medical Technology Innovation Scorecard: The Race for Global Leadership." Findings suggest that the U.S. medical device industry failed to cope with emerging markets such as China, Brazil and India as a global innovation...

  • Are drugs made abroad safe to take?  // Consumer Reports on Health;Sep2014, Vol. 26 Issue 9, p9 

    The article discusses safety issues that have been found to be associated with medications that are sold in the U.S. and are manufactured in foreign countries, including India and China. Warning letters related to drug manufacturing which the U.S. Food and Drug Administration sent to drug...

  • Global standards pave the way for unique device identification. Lamb, Roger // International Journal of Therapy & Rehabilitation;Jun2013 Equipment Services, p38 

    The author discusses the European Union's mandatory universal adoption of unique device identifiers on medical devices and its impact on medical procurement in England and Wales. He describes the identifier as a unique number of alphanumeric code for a medical device that allows identification...

  • First step taken in FDA-issued unique device identification system. Hanoon, Mai // OR Manager;3/1/2015, Issue 3, p1 

    The article focuses on the seven-year unique device identification (UDI) process mandated by the U.S. Food and Drug Administration (FDA) to label and track medical devices. It includes comments from Rose Trojkovich of New Jersey-based Englewood Hospital and Medical Center, on use of the UDI...

  • Report suggests steps to improve safety of drug supply. Traynor, Kate // American Journal of Health-System Pharmacy;9/1/2011, Vol. 68 Issue 17, p1570 

    The article discusses the report "After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit Drugs," by Pew Charitable Trusts' Health Group. The issues raised by the report include the need for a track-and-trace system, uniform standards for unit-of-use-level drug product...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics